Downloads provided by UsageCounts
LRP1-targeted St-Cl–polyglutamate conjugates as multivalent neuroprotective/neurotrophic therapeutics for Alzheimer’s disease.
570, Amyloid beta-Peptides, Alzheimer’s disease (AD), Mice, Transgenic, Nanoconjugates, Hippocampus, AD treatment, Disease Models, Animal, Mice, Alzheimer Disease, 616, Animals, Research Articles
570, Amyloid beta-Peptides, Alzheimer’s disease (AD), Mice, Transgenic, Nanoconjugates, Hippocampus, AD treatment, Disease Models, Animal, Mice, Alzheimer Disease, 616, Animals, Research Articles
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 53 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
| views | 33 | |
| downloads | 65 |

Views provided by UsageCounts
Downloads provided by UsageCounts